EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A self-assembled nanoparticle vaccine displaying chimeric and trimeric RBD-HRC elicits broad-spectrum neutralizing antibodies against multiple coronaviruses

Didi Wan, Lili Li, He Feng, Mengyu Wang, Shuo Jia, Pengyu Zhang, Jiaxu Wang, Junxia Yang, Yijie Zhang, Boya Ji, Yushun Wan iD, Zhengkun Xie und 1 weitere

Microbiology Spectrum · 05.05.2026 · 14 (5)

DOI: 10.1128/spectrum.03797-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.05.2026. Verfasst von Didi Wan und 12 weiteren Autor:innen. Beteiligte Einrichtung: BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronaviruses, known for their high mutation rates and character of cross-species transmission, continue to pose significant threats to global health, as demonstrated by outbreaks of SARS, MERS, and SARS-CoV-2. Vaccines remain the most effective means of preventing viral infection, transmission, and epidemic spread. However, traditional vaccine development faces significant challenges due to the rapid evolution of viruses and their ability to evade the immune system. In response, we present a novel vaccine design based on self-assembling nanoparticles that display multiple glycosylation-modified receptor-binding domain-heptad repeat C-domain (RBD-HRC) trimers, forming a multimerized, polyvalent chimeric RBD-HRC vaccine. This approach enhances immunogenicity by closely mimicking the native structure of the spike protein, thereby eliciting broad-spectrum neutralizing antibodies that can target coronavirus-derived pseudoviruses from different genera. Notably, it even demonstrates neutralizing activity against coronaviruses not included in the vaccine design. Additionally, this vaccine formulation induces a robust cellular immune response. The multivalent nature of the nanoparticle vaccine promotes stronger T-cell activation and exhibits enhanced broad-spectrum activity. Our strategy offers a scalable and versatile platform for the development of vaccines against a wide range of viral pathogens. IMPORTANCE Broad-spectrum vaccines are urgently needed to control the rapid evolution of viruses and their cross-species transmission. The effective presentation of epitopes, especially conserved ones, plays a critical role in vaccine design. Moreover, the polymerization of epitopes has been shown to significantly enhance immunogenicity. In this study, we present a scalable platform for developing broad-spectrum vaccines against rapidly evolving pathogens. This vaccine platform, based on self-assembling nanoparticles, displays glycosylation-modified coronavirus spike receptor-binding domain-heptad repeat C-domain (RBD-HRC) trimers, enabling the formation of multimerized and polyvalent chimeric antigens. We found that the trivalent RBD-HRC nanoparticle vaccine elicits the broadest neutralizing antibody response, strongest T-cell activation, and highest neutralization potency compared to other formulations, offering valuable insights for future vaccine development.

Schlagwörter

Stichwörter der Autor:innen

broad-spectrumcoronavirusesnanoparticlevaccine design

Autor:innen und Institutionen

  • BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • College of Life Sciences, Henan Normal University, Xinxiang, Henan, China.
  • College of Basic Medicine, Chongqing Medical University, Chongqing, Chongqing, China.
  • College of Chemistry, Zhengzhou University, Zhengzhou, Henan, China.
  • State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.

ORCID-Profile: Yushun Wan, Jian Shang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wan, D., Li, L., Feng, H., Wang, M., Jia, S., Zhang, P., Wang, J., Yang, J., Zhang, Y., Ji, B., Wan, Y., Xie, Z., & Shang, J. (2026). A self-assembled nanoparticle vaccine displaying chimeric and trimeric RBD-HRC elicits broad-spectrum neutralizing antibodies against multiple coronaviruses. Microbiology Spectrum, 14(5). https://doi.org/10.1128/spectrum.03797-25

Vancouver

Wan D, Li L, Feng H, Wang M, Jia S, Zhang P, et al. A self-assembled nanoparticle vaccine displaying chimeric and trimeric RBD-HRC elicits broad-spectrum neutralizing antibodies against multiple coronaviruses. Microbiology Spectrum. 2026;14(5). doi:10.1128/spectrum.03797-25

BibTeX
@article{Wan2026,
  author = {Wan, Didi and Li, Lili and Feng, He and Wang, Mengyu and Jia, Shuo and Zhang, Pengyu and Wang, Jiaxu and Yang, Junxia and Zhang, Yijie and Ji, Boya and Wan, Yushun and Xie, Zhengkun and Shang, Jian},
  title = {A self-assembled nanoparticle vaccine displaying chimeric and trimeric RBD-HRC elicits broad-spectrum neutralizing antibodies against multiple coronaviruses},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {5},
  doi = {10.1128/spectrum.03797-25}
}
Kostenlos starten →